Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2002
07/24/2002CN1360588A Hemisynthetic method and intermediate thereof
07/24/2002CN1360583A Novel compounds, their use and preparation
07/24/2002CN1360582A Quinazoline derivs.
07/24/2002CN1360581A Benzoylpyridazines
07/24/2002CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors
07/24/2002CN1360572A Vitamin D3 Analogs
07/24/2002CN1360571A Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs.
07/24/2002CN1360570A Phenyl sulfamate derivs.
07/24/2002CN1360568A Diacylhydrazine derivs.
07/24/2002CN1360567A Sphingoid base devivs. and uses thereof
07/24/2002CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
07/24/2002CN1360505A Pseudomycin antifungal compositions and method for their use
07/24/2002CN1360504A Taste masked pharmaceutical liquid formulations
07/24/2002CN1360503A Compositions and uses of ET 743 for treating cancer
07/24/2002CN1360502A Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
07/24/2002CN1360501A Treatment of neurotic disorders
07/24/2002CN1360500A Use of sulfamate derivs. for treating impulse control disorders
07/24/2002CN1360499A Pharmaceutical composition contg. fenofibrate and preparation method
07/24/2002CN1360498A Carboxylic acid derivs. that inhibit binding of integrins to their receptors
07/24/2002CN1360497A Controlled-release biocompatible ocular drug delivery implant devices and methods
07/24/2002CN1360495A Intravaginal clindamycin ovule composition
07/24/2002CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip
07/24/2002CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances
07/24/2002CN1360467A Antimicrobial sanitizing lotion with skin protection properties
07/24/2002CN1359900A Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same
07/24/2002CN1359721A Medicine for controlling sex of calf
07/24/2002CN1359699A Detoxicating and hypolipemic capsule
07/24/2002CN1359682A Breviscapine-phosphotide compound and its preparing process
07/24/2002CN1359681A Mometasone furoate as nasal spray and its preparing process
07/24/2002CN1359680A Prescription of preparing moxapride citrate
07/24/2002CN1359679A Medicine for dropping off drug and its preparing process
07/24/2002CN1359678A Process for preparing houttuyninum sodium injection
07/24/2002CN1359677A Preparation of propofol with enhanced bacteria inhibition
07/24/2002CN1359675A Use of benzodihydropyran deriv. in beauty or dermatology preparation
07/24/2002CN1088068C Ascomycins
07/24/2002CN1088064C Naphthoxazines derivs., process for their preparation and pharmaceutical compositions contg. them
07/24/2002CN1088062C Certain 4-aminomethy-2-substd. imidazole derivs. and 2-aminomethyl-4-substd. imidazole derivs. new classes of dopamine receptor subtype specific ligands
07/24/2002CN1088058C Modified polyunsaturated fatty acids
07/24/2002CN1087948C Burn and scald treating liquid
07/24/2002CN1087943C Stable extract of hyperricum perforatum, process for preparing same and pharmaceutical compositions
07/24/2002CN1087938C 东莨菪碱膏药 Scopolamine plaster
07/24/2002CN1087937C Medicine of inhibiting Alzheimer's disease
07/24/2002CN1087936C Use of thiadiazole and oxadiazole derivs. in preparing antipsychotic medicine
07/24/2002CN1087935C Medicaments
07/24/2002CN1087934C Use of phenalkylamines
07/24/2002CN1087933C Encapsulated medicine
07/24/2002CN1087932C Proliposome powder for inhalation
07/23/2002US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same
07/23/2002US6423855 Prevention lysis; oxidation resistance
07/23/2002US6423854 Aminophenol derivatives and their use in cosmetics
07/23/2002US6423842 Act preferentially on m4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; alzheimer's disease; cognition activators.
07/23/2002US6423840 Forming n-acylamino compound
07/23/2002US6423754 Method for treating hypercholesterolemia with polyallylamine polymers
07/23/2002US6423753 Controlling angiogenesis
07/23/2002US6423752 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity
07/23/2002US6423751 Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
07/23/2002US6423750 Systems for delivering anti-infective compositions to treat disordered tissue such as cold sores
07/23/2002US6423749 Pharmaceutical composition for injection based on paracetamol
07/23/2002US6423748 Contact lenses antiseptic
07/23/2002US6423747 Cosmetic and dermatological preparations with flavonoids
07/23/2002US6423746 Topical mixture of nonylphenol ethoxylate and sodium lauryl sarcosinate
07/23/2002US6423744 Administering an amount of a leukotriene b4 (ltb4) antagonist, preferably a ltb4 receptor antagonistic, to a patient exhibiting adverse drug effect due to exogenous interleukin-2, to decrease the adverse effects
07/23/2002US6423743 Analyzing for gene for expression of procyanidin
07/23/2002US6423742 Synergistic mixture of limonene and gallic acid
07/23/2002US6423741 Anti-microbial composition and method for producing the same
07/23/2002US6423739 Method for aiding cerebral recovery following neurodegeneration
07/23/2002US6423738 Administering melatonin
07/23/2002US6423737 Benzamidoxime prodrugs as antipneumocystic agents
07/23/2002US6423736 Administering benzimidazole compound
07/23/2002US6423735 Administering benzimidazole compound
07/23/2002US6423734 Administering benzimidazole compound
07/23/2002US6423729 Therapeutic or prophylactic agent for glomerulopathy
07/23/2002US6423728 Heterocyclic thioamide derivatives
07/23/2002US6423727 Certain thiol inhibitors of endothelin-converting enzyme
07/23/2002US6423725 Analgesics
07/23/2002US6423723 Oral bioavailability
07/23/2002US6423722 Antiinflammatory agents
07/23/2002US6423721 Administering dosage descarboethoxylotadine
07/23/2002US6423720 Pyrimidine compounds and methods for making and using the same
07/23/2002US6423719 Method for treating benign prostate hyperplasia
07/23/2002US6423717 Nervous system disorders
07/23/2002US6423713 Substituted pyrazoles as p38 kinase inhibitors
07/23/2002US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
07/23/2002US6423710 Cyclic AMP-specific phosphodiesterase inhibitors
07/23/2002US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2002US6423706 Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
07/23/2002US6423705 Combination therapy
07/23/2002US6423703 Use of a porphyrin for producing a medicine reducing the number of eosinophils
07/23/2002US6423702 Process for the hydroxylation of an acyclic or cyclic methylene radical in the allylic position, pharmaceutical composition containing hydroxycholesterol derivatives and utilization of such compositions for the preparation of drugs
07/23/2002US6423700 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
07/23/2002US6423699 Contraceptives
07/23/2002US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia
07/23/2002US6423697 Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
07/23/2002US6423696 Inhibition of arylamine N-acetyl transferase
07/23/2002US6423695 Cytokine related treatments of disease
07/23/2002US6423694 Method of treating otitis media with uridine triphosphates and related compounds
07/23/2002US6423692 Transducing a target cell with a nucleic acid sequence encoding a dck protein (deoxycytidine kinase) having phosphorylation activity operably linked to a promoter
07/23/2002US6423691 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytography
07/23/2002US6423690 Antibacterial agents
07/23/2002US6423687 Pharmaceutical preparations of glutathione and methods of administration thereof